Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells - PubMed (original) (raw)
. 2002 Sep 1;11(18):2091-102.
doi: 10.1093/hmg/11.18.2091.
Affiliations
- PMID: 12189161
- DOI: 10.1093/hmg/11.18.2091
Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells
Qian Tao et al. Hum Mol Genet. 2002.
Abstract
ICF syndrome (immunodeficiency, centromere instability and facial anomalies) is a recessive human genetic disorder resulting from mutations in the DNA methyltransferase 3B (DNMT3B) gene. Patients with this disease exhibit numerous chromosomal abnormalities, including anomalous decondensation, pairing, separation and breakage, primarily involving the pericentromeric regions of chromosomes 1 and 16. Global levels of DNA methylation in ICF cells are only slightly reduced; however, certain repetitive sequences and genes on the inactive X chromosome of female ICF patients are significantly hypomethylated. In the present report, we analyze the molecular defect of de novo methylation in ICF cells in greater detail by making use of a model Epstein-Barr virus (EBV)-based system and three members of the unique cellular cancer-testis (C-T) gene family. Results with the EBV-based system indicate that de novo methylation of newly introduced viral sequences is defective in ICF syndrome. Limited de novo methylation capacity is retained in ICF cells, indicating that the mutations in DNMT3B are not complete loss-of-function mutations or that other DNMTs cooperate with DNMT3B. Analysis of three C-T genes (two on the X chromosome and one autosomal) revealed that loss of methylation from cellular gene sequences is heterogeneous, with both autosomal and X chromosome-based genes demonstrating sensitivity to mutations in DNMT3B. Aberrant hypomethylation at a number of loci examined correlated with altered gene expression levels. Lastly, no consistent changes in the protein levels of the DNA methyltransferases were noted when normal and ICF cell lines were compared.
Similar articles
- The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.
Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, Weemaes CM, Gartler SM. Hansen RS, et al. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14412-7. doi: 10.1073/pnas.96.25.14412. Proc Natl Acad Sci U S A. 1999. PMID: 10588719 Free PMC article. - DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients.
Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, Fiala ES, Sohn OS, Ehrlich M. Tuck-Muller CM, et al. Cytogenet Cell Genet. 2000;89(1-2):121-8. doi: 10.1159/000015590. Cytogenet Cell Genet. 2000. PMID: 10894953 - DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
Jin B, Tao Q, Peng J, Soo HM, Wu W, Ying J, Fields CR, Delmas AL, Liu X, Qiu J, Robertson KD. Jin B, et al. Hum Mol Genet. 2008 Mar 1;17(5):690-709. doi: 10.1093/hmg/ddm341. Epub 2007 Nov 20. Hum Mol Genet. 2008. PMID: 18029387 - [Clinical and genetic manifestations of immunodeficiency, centromeric instability, and facial anomalies syndrome: a case report and literature review].
Hu SC, Wang YB, Sun Q, Liu XR, Sun LL, Cui GM. Hu SC, et al. Zhonghua Er Ke Za Zhi. 2019 Jan 2;57(1):55-59. doi: 10.3760/cma.j.issn.0578-1310.2019.01.013. Zhonghua Er Ke Za Zhi. 2019. PMID: 30630233 Review. Chinese. - The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease.
Ehrlich M. Ehrlich M. Clin Immunol. 2003 Oct;109(1):17-28. doi: 10.1016/s1521-6616(03)00201-8. Clin Immunol. 2003. PMID: 14585272 Review.
Cited by
- Replication profile of PCDH11X and PCDH11Y, a gene pair located in the non-pseudoautosomal homologous region Xq21.3/Yp11.2.
Wilson ND, Ross LJ, Close J, Mott R, Crow TJ, Volpi EV. Wilson ND, et al. Chromosome Res. 2007;15(4):485-98. doi: 10.1007/s10577-007-1153-y. Epub 2007 May 29. Chromosome Res. 2007. PMID: 17671842 Free PMC article. - Apoptosis and DNA methylation.
Meng HX, Hackett JA, Nestor C, Dunican DS, Madej M, Reddington JP, Pennings S, Harrison DJ, Meehan RR. Meng HX, et al. Cancers (Basel). 2011 Apr 1;3(2):1798-820. doi: 10.3390/cancers3021798. Cancers (Basel). 2011. PMID: 24212783 Free PMC article. - A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca2+/Calpain-mediated proteolysis of FAK and suppression of PI3K/Akt/mTOR signaling pathway.
Wang C, Chen J, Kuang Y, Cheng X, Deng M, Jiang Z, Hu X. Wang C, et al. Int J Biol Sci. 2022 Sep 1;18(14):5575-5590. doi: 10.7150/ijbs.70504. eCollection 2022. Int J Biol Sci. 2022. PMID: 36147460 Free PMC article. - Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.
Zhao H, Li Q, Wang J, Su X, Ng KM, Qiu T, Shan L, Ling Y, Wang L, Cai J, Ying J. Zhao H, et al. PLoS One. 2012;7(11):e49683. doi: 10.1371/journal.pone.0049683. Epub 2012 Nov 13. PLoS One. 2012. PMID: 23152928 Free PMC article. - eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/β-catenin in gastric cancer.
Zhai S, Lin S, Lin Z, Xu J, Ji T, Chen K, Wu K, Liu H, Ying H, Fei W, Wang J, Fu G, Wang Y, Hu X, Cai X. Zhai S, et al. Gastric Cancer. 2020 May;23(3):483-496. doi: 10.1007/s10120-019-01030-x. Epub 2019 Dec 18. Gastric Cancer. 2020. PMID: 31853750
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources